News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osmetech Plc (OMH) Clinical Trials Commence for Extended Warfarin Sensitivity Test



11/10/2008 12:10:48 PM

LONDON--(BUSINESS WIRE)--Osmetech plc (LSE:OMH), the international molecular diagnostics company announces that it has now commenced clinical trials for an extended warfarin sensitivity test.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES